Title |
Early versus delayed initiation of antiretroviral therapy for Indian HIV-Infected individuals with tuberculosis on antituberculosis treatment
|
---|---|
Published in |
BMC Infectious Diseases, July 2012
|
DOI | 10.1186/1471-2334-12-168 |
Pubmed ID | |
Authors |
Sanjeev Sinha, Rahul C Shekhar, Gurjeet Singh, Nipam Shah, Hafiz Ahmad, Narendra Kumar, Surendra K Sharma, JC Samantaray, Sanjai Ranjan, Meera Ekka, Vishnu Sreenivas, Ronald T Mitsuyasu |
Abstract |
For antiretroviral therapy (ART) naive human immunodeficiency virus (HIV) infected adults suffering from tuberculosis (TB), there is uncertainty about the optimal time to initiate highly active antiretroviral therapy (HAART) after starting antituberculosis treatment (ATT), in order to minimize mortality, HIV disease progression, and adverse events. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Malaysia | 1 | <1% |
United Kingdom | 1 | <1% |
Spain | 1 | <1% |
Tanzania, United Republic of | 1 | <1% |
Unknown | 107 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 24 | 22% |
Student > Bachelor | 14 | 13% |
Researcher | 13 | 12% |
Student > Ph. D. Student | 12 | 11% |
Student > Postgraduate | 10 | 9% |
Other | 17 | 15% |
Unknown | 21 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 53 | 48% |
Nursing and Health Professions | 8 | 7% |
Agricultural and Biological Sciences | 7 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
Immunology and Microbiology | 3 | 3% |
Other | 11 | 10% |
Unknown | 24 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 November 2019.
All research outputs
#3,240,393
of 25,330,051 outputs
Outputs from BMC Infectious Diseases
#1,091
of 8,539 outputs
Outputs of similar age
#20,459
of 170,593 outputs
Outputs of similar age from BMC Infectious Diseases
#9
of 84 outputs
Altmetric has tracked 25,330,051 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,539 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 170,593 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 84 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.